Research Associate, Translational and Clinical Biomarkers
Boston, MA - USA
Job Summary
Monte Rosa Therapeutics seeks an experienced and highly motivated scientist to join our Biomarker and Translation team in Boston. Using a rational approach to targeted protein degradation Monte Rosa is developing pioneering therapies across Immunology & Inflammation Oncology and other disease areas. The individual in this role will be responsible for designing and executing robust translational experiments in clinically relevant models to support indication selection and patient stratification. He/she will work in close collaboration with translational/biomarker project and clinical teams to develop and implement internal and external biomarker activities and perform studies to support indication/patient selection opportunities.
- Independently develop and execute experiments in relevant models
- Interpret translational data generate reports and present findings
- Ensure the timely delivery of high-quality data to support key decisions
- Design study plans SOPs templates validation reports and other relevant documentation
- Maintain laboratory instruments reagents consumables and perform other routine laboratory tasks
- BS/MS degree in Immunology or Cell Biology with wide experience as laboratory technician with 3 years hands-on experience in a pharmaceutical setting
- Extensive experience with molecular biology techniques including but not limited to CRISPR gene editing ELISA MSD and flow cytometry
- Prior experience in working with human samples (blood solid tissue) and primary cell cultures
- Ability to maintain timely and detailed notes using electronic lab notebook as well as demonstrated experience using Microsoft Excel and GraphPad Prism
- Excellent interpersonal skills and willingness to learn a variety of new techniques and biological approaches; ability to work in a matrixed team and adapt to rapidly changing priorities and deadlines
Required Experience:
IC
About Company
Pioneering Therapies for Cancer and Beyond – Our drug discovery platform is tailored to promote specific protein ubiquitination and subsequent proteasomal degradation of disease-causing, undruggable proteins, in essence leading to pharmacological protein knockout with high efficiency ... View more